Skip to main content
Premium Trial:

Request an Annual Quote

Genewiz, KeyTest Collaborate on MDx Development in China

NEW YORK (GenomeWeb News) – Genewiz and KeyTest Diagnostics today announced a collaboration aimed at developing molecular diagnostic tests for the Chinese market.

In addition to developing tests using cutting-edge genomics technologies, the partners said they aim to establish clinical testing standards.

"Partnering with KeyTest Diagnostics will enable Chinese customers to gain access to clinical tests that are critical to disease treatment and their overall health," Amy Liao, president and COO of South Plainfield, NJ-based Genewiz said in a statement. "Together, we will have the ability to develop and introduce more clinical tests in China, thus helping to make a difference in the pursuit of scientific discoveries and better medicines around the globe."

Financial and other terms of the deal were not disclosed.

Genewiz is a contract research organization specializing in genomics services, including DNA sequencing, gene synthesis, and molecular biology. Among its products are OncoGxOne cancer panels for detecting genomic aberrations. The panels can be used for therapeutic target and biomarker discovery, as well as patient stratification for clinical trials, it said.

KeyTest is headquartered in Suzhou, China, and is a third-party medical testing center. Its specialties include laboratory management, molecular diagnostics, clinical immunology, and oncology, among others.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.